Internal Medicine, Gastroenterology · Los Angeles, CA
NPI
1962780148
Since 2011
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
200 Med Plaza Suite 365, 420, 120
Los Angeles, CA, 90095
Phone (818) 461-8148
Groups this clinician bills Medicare through
Medicare paid, 2024
$99K
1,009 services
Medicare patients, 2024
416
Average age 73
Drug cost, 2024
$540K
2,124 prescriptions
Company payments, 2025
$304
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Daniel D Eshtiaghpour was code 99214 (office e&m - established), 281 times for 184 patients. In total Daniel D Eshtiaghpour billed 1,009 services in 28 codes, and Medicare paid $99K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-08-01.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 281 | 184 | $102.99 | $29K |
| 99204 Office E&M - New | Office | 208 | 208 | $130.27 | $27K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 201 | 155 | $13.58 | $2,729 |
| 43239 Upper GI Endoscopy | Facility | 85 | 85 | $82.88 | $7,045 |
| 45380 Lower GI Endoscopy - Other | Facility | 56 | 56 | $115.34 | $6,459 |
| 45385 Colonoscopy - Lesion Removal | Facility | 46 | 46 | $219.79 | $10K |
| 99215 Office E&M - Established | Office | 46 | 34 | $142.65 | $6,562 |
| G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 20 | 20 | $179.57 | $3,591 |
By year: 2022 $105K for 915 services; 2023 $94K for 768 services; 2024 $99K for 1,009 services.
Medicare prescription drug claims, 2024
In 2024, the drug Daniel D Eshtiaghpour prescribed most often to Medicare patients was Pantoprazole Sodium, with 514 prescriptions and refills. In total Daniel D Eshtiaghpour wrote 2,124 Medicare prescriptions that cost $540K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Pantoprazole Sodium Generic | 514 | 963 | 180 | $8,244 |
| Omeprazole Generic | 214 | 360 | 73 | $3,069 |
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 179 | 179 | 174 | $10K |
| Sucralfate Generic | 159 | 173 | 59 | $6,078 |
| Linzess Linaclotide | 108 | 138 | 34 | $72K |
| Famotidine Generic | 103 | 224 | 41 | $2,630 |
| Dicyclomine Hcl Generic | 87 | 104 | 42 | $1,686 |
| Colestipol Hcl Generic | 81 | 136 | 33 | $4,609 |
| Ondansetron Odt Ondansetron | 52 | 54 | 28 | $1,767 |
| Creon Lipase/Protease/Amylase | 39 | 46 | Under 11 | $66K |
| Dexlansoprazole Dr Dexlansoprazole | 30 | 48 | Under 11 | $6,470 |
| Nortriptyline Hcl Generic | 27 | 39 | Under 11 | $184 |
| Mesalamine Generic | 24 | 49 | Under 11 | $10K |
| Diphenoxylate-Atropine Diphenoxylate Hcl/Atropine | 23 | 23 | 12 | $502 |
| Loperamide Loperamide Hcl | 23 | 27 | Under 11 | $540 |
Brand drugs: 358 claims; generic drugs: 1,766 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Daniel D Eshtiaghpour $304 ($304 in general payments such as food, travel and fees) from 5 companies. The largest payer was Abbvie Inc. with $149.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.